Related Experiment Video
Updated: Jun 6, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
The clinical utility of precision medicine: properly assessing the value of emerging diagnostic tests
Abstract:
Assessments of the clinical utility of biomarkers and genomic tests often ignore individual utility and fail to account for downstream changes to the care delivery model. Tests that identify outliers are often undervalued in favor of those that help direct treatment for the "average" patient. By reducing uncertainty, these tests also enable lower-cost providers and even patients to assume increased responsibility for care in more convenient and affordable settings.
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Pharmacogenomics: Identification of New Drug Targets
Automated Microbial Diagnostics
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Rapid Identification of Pathogens